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BRIEF COMMUNICATION
DETECTION OF NON-ENTEROTOXIGENIC AND ENTEROTOXIGENIC Bacteroides fragilis IN STOOL
SAMPLES FROM CHILDREN IN SÃO PAULO, BRAZIL
Flávio KRZYZANOWSKY & Mario J. AVILA-CAMPOS
SUMMARY
Non-enterotoxigenic bacteria of the Bacteroides fragilis group and enterotoxigenic B. fragilis were identified from children with
and without aqueous acute diarrhea. In this study, 170 stool samples from 96 children with and 74 without diarrhea were analyzed.
Enterotoxin production and the toxin gene detection were detected by cytotoxicity assay on HT-29/C1 cells and by PCR, respectively.
B. fragilis species was prevalent in both groups and enterotoxigenic B. fragilis strains were isolated from two children with diarrhea.
More studies are important to evaluate the role of each bacteria of the B. fragilis group, including enterotoxigenic strains play in the
diarrheal processes in children.
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Bacteroides fragilis is considered to be an important member of the
human intestinal indigenous microbiota and in various experimental
animal models B. fragilis has been reported to be more virulent than the
other species from the B. fragilis group3.
The involvement of B. fragilis in the etiology of human and animal
diarrhea has been the subject of some investigations in the last years6,11.
Childhood diarrhea is one of the most important causes of morbidity
and mortality worldwide5. MYERS et al.10 reported B. fragilis strains
producing an enterotoxin (ETBF) that causes diarrhea in young farm
animals and which is associated with diarrhea in man2,7,14,15.
The enterotoxin or fragilisyn has been characterized as a zinc-
metalloprotease with a molecular weight of 20,000 Da, and with activity
against tight junction proteins, disrupting the intestinal epithelial
barrier9,12,13 and inducing fluid losses19. In this study, the isolation and
identification of bacteria of the B. fragilis group and the detection of the
ETBF in stool samples of children with and without diarrhea were
performed.
Fresh stool samples from ninety-six hospitalized children with
aqueous acute diarrhea from two hospitals (Menino Jesus Hospital and
Instituto da Criança, São Paulo, SP, Brazil) and from 74 healthy children
from two different day care centers, aged one month to 12 years old,
without sex distinction were analyzed. The Ethic Commission from both
hospitals approved this study. Collected stools from children with or
without diarrhea were immediately plated onto a selective B. fragilis-
bile-esculin agar8 (BBE, Difco Laboratories) and incubated in atmosphere
with 90% N2/10% CO2, at 37 °C, for 72 hours. Characteristic dark colonies
grown in BBE were subcultured on blood agar (BHI agar - Difco, enriched
with 5% sheep desfibrined blood). Isolates were identified by using
identification kits API 32-A (bioMérieux) and stored in 10% skim milk
at -70 °C.
Two of the enterotoxin-positive strains were used as control: B.
fragilis ATCC 43858 and B. fragilis GAI 97124, kindly provided by Dr
Annalisa Pantosti (Laboratory of Bacteriology and Medical Mycology,
“Istituto Superiore di Sanità”, Rome, Italy) and by Dr Naoki Kato
(Institute of Anaerobic Bacteriology, Gifu University School of Medicine,
Gifu, Japan), respectively.
Bacteria from B. fragilis group were grown in brain heart infusion
broth (BHI, Difco) supplemented with 0.5% yeast extract (Difco) in
anaerobiosis, at 37 °C, for 48 hours and centrifuged (13,000 g, 5 minutes).
Supernatant and pellet were separately collected and stored at -20 °C.
Cytotoxic assay was performed according BRESSANE et al.1 in HT-29/
C1 cells grown in Eagle medium (Gibco BRL, Life Technologies)
supplemented with 100 IU penicillin ml-1, 100 µg streptomycin ml-1 and
heat-inactivated fetal bovine serum (15%) in air plus 5%-CO2, at 37 oC.
Then, 20 µl of bacterial supernatant were inoculated into each well, in
duplicate, and plates were incubated (air- 5%-CO2, at 37 oC), and
examined after 3-4 hours for the presence of the typical toxin-induced
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cellular alterations14. Bacterial pellets mixed with 500 µl of Milli-Q water,
washed twice (12,000 g, for 15 minutes), and resuspended in 500 µl of
Milli-Q water were used for DNA extractions by boiling for 10 minutes.
After centrifugation (14,000 g, 10 minutes) the supernatant was saved
and used as template. Primers were synthesized according to PANTOSTI
et al.16 at the Biotechnology Branch, Centers for Disease Control and
Prevention (CDC, Atlanta, GA, USA). For positive isolates the specific
primer pair amplified a characteristic 294-bp fragment. DNA
amplifications were performed in 25 µl containing 2.5 µl of 10 X PCR
buffer (Gibco), 1.25 µl of MgCl2 (1.5 mM), 2.0 µl of dNTP mixture
(0.2 mM) (Gibco), 0.25 µl of Taq DNA polymerase (0.5 U) (Gibco),
1 µl of each primer (0.4 mM), 7 µl of ultrapure water (Milli-Q plus) and
10 µl of DNA template. Amplification was performed in a DNA thermal
cycler (Perkin Elmer, Amp PCR System 2400) programmed for 94 oC
(five minutes) followed by 35 cycles of 94 oC (one minute), 52 oC (one
minute), 72 oC (one minute), and then 72 oC (five minutes). A negative
control without template was included in each PCR run. Amplified
products were visualized by electrophoresis in 1.6% agarose gel in 1X
TBE buffer (1 M Tris, 0.9 M boric acid, 0.01 M EDTA, pH 8.4), at 80 v,
for two hours. A 50 bp DNA Ladder (Gibco) was used as a molecular
mass marker. Gels were stained with ethidium bromide (0.5 µg ml-1) and
photographed on a UV light transilluminator (Electrophoresis
Documentation and Analysis System 120, Kodak Digital Science).
Bacterial isolation from both patient and control groups was analyzed
by using a χ2 test.
The incidence of bacteria of the B. fragilis group, non-enterotoxigenic
B. fragilis (non-ETBF), and ETBF isolated from hospitalized children
with aqueous acute diarrhea and from healthy children without diarrhea
can be observed in Table 1. 0nly children with diarrhea harbored ETBF
species (2.08%). Non-ETBF B. fragilis were isolated in 11 (11.45%)
children with diarrhea and in 18 (24.3%) without diarrhea (Table 1).
Also, the bacterial species that belonged to B. fragilis group isolated
from children with and without diarrhea are shown in Table 2. All the
recovered bacteria from children with and without diarrhea were
examined for enterotoxigenicity on HT-29/C1 cell and by PCR, and only
ETBF were toxigenic and produced a characteristic 294 bp fragment.
ETBF were isolated and detected in two children with diarrhea (8 months
and 4 years old). No healthy children without diarrhea harbored ETBF.
B. fragilis species are emerging as etiologic agents of diarrhea in
farm animals and humans11. ETBF detection from stools is amount-
dependent of produced toxin, assay sensitivity, and toxin stability, but
the toxin is susceptible for protease action13.
Currently, the identification of enterotoxin production is achieved
by culturing in selective medium (BBE) and by testing the isolates for
the presence of enterotoxin by the cytotoxic assay with HT-29/C1 cells15
or lambs ileal loop test11. In this study, the bacterial isolation from both
patient and control groups was not significant (P > 0.05, Table 1).
Hospitalized children were not using antimicrobial agents at the time of
sampling. Although, it is suggested that some factors such as
immunological alterations, age, nutritional conditions, genetic factors
or pathologies could interfere in the B. fragilis isolation4,20.
Bacteria of the B. fragilis group were isolated from 50% control
group, in accordance with similar studies in Italian children (46%) and
in Apache American children (50%)15,17. Non-ETBF was observed in
24.3% of this control group. The presence of ETBF has been associated
with acute diarrhea in children older than one year-old in USA, Italy,
Sweden and Japan15,17,18,20, and recently in Nicaraguan children younger
than one-year old2. Also, these studies showed that patients with or
without diarrhea could harbor ETBF in their intestinal tract, but these
organisms might be in a small number in the human intestinal indigenous
microbiota15. In our study, ETBF were isolated and detected from two
children with diarrhea and its presence was not significant, however,
other enteropathogens such as rotavirus, EPEC, ETEC, or Vibrio cholerae
were not found, but they could be implicated in diarrhoeal processes in
Brazil1. Moreover, these results indicate the need of more studies to
evaluate the role that each bacteria of the B. fragilis group, including
non-ETBF and ETBF, play in the childhood diarrhea.
RESUMO
Detecção de Bacteroides fragilis enterotoxigênicos e não
enterotoxigênicos de amostras fecais de crianças em São Paulo,
Brasil
Bactérias não enterotoxigênicas do grupo Bacteroides fragilis e B.
fragilis enterotoxigênicas foram isoladas e identificadas de crianças com
e sem diarréia aguda aquosa. Neste estudo, 170 amostras fecais de 96 e
74 crianças, com e sem diarréia, respectivamente, foram analisadas. A
produção de enterotoxina e a detecção do gene que media a produção da
toxina foram determinadas por ensaios citotóxicos em células HT-29/C1
e por PCR, respectivamente. A espécie B. fragilis foi prevalente em ambos
Table 1
Incidence of the B. fragilis group, non-ETBF and ETBF in stool samples
obtained from 96 patients and 74 healthy children samples
Isolates With diarrhea (96) Without diarrhea (74)
No. % No. %
B. fragilis group 16 16.6a 37 50b
Non-ETBF 11 11.45* 18 24.3*
ETBF 2 2.08* 0 0
*No significant difference; a x b = P < 0.05.
Table 2
Occurrence of bacteria of the B. fragilis group in 170 stool samples from
children with and without aqueous acute diarrhea
Bacterial  Diarrhea No diarrhea
Isolates No. % No. %
Non-ETBF  67  72.82 42  53.84
ETBF 2 2.17 0 0
B. distasonis  11  11.95  17  21.79
B. uniformis  7  7.6  1  1.28
B. vulgatus  4  4.34  13  16.66
B. thetaiotaomicron  1  1.08 1  1.28
B. ovatus  0  0 4  5.12
Total  92  100  78 100
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os grupos, e cepas de B. fragilis enterotoxigênicas foram isoladas de
duas crianças com diarréia aquosa aguda. Maiores estudos são necessários
para avaliar o papel de cada bactéria desse importante grupo bacteriano,
incluindo-se o papel que as cepas enterotoxigênicas, desempenham no
processo diarréico em crianças.
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